Virbac Reports on Shares and Voting Rights for Investors
Overview of Virbac's Share and Voting Rights Declaration
Virbac aims to maintain a clear and transparent relationship with its shareholders. This recent declaration outlines the number of shares and the corresponding voting rights associated with them, ensuring all stakeholders are informed.
Details of the Declaration
The information provided in the declaration is essential for understanding the company's capital structure. It shows that the total number of shares constituting the capital is significant, reflecting the robust nature of Virbac’s financial health.
Key Figures
As of the given date, the total number of shares is noted as 8,390,660. This figure represents the company's commitment to its shareholders and emphasizes the importance of active participation in corporate governance.
Understanding Voting Rights
The declaration covers not just the number of shares, but also the voting rights associated with them. The gross total of voting rights is reported at 12,706,430, showcasing the strong governance framework within the company. The net total of voting rights, taking into account shares devoid of voting rights, is slightly lower at 12,690,364. This distinction is crucial for investors.
Importance of Transparency
Being transparent about shareholding and voting rights contributes significantly to shareholder confidence. By making this information accessible, Virbac demonstrates its dedication to ensuring that investors are well informed about their positions within the company.
Virbac's Commitment to Animal Health
Virbac is dedicated to shaping the future of animal health. Operating under ISIN code FR0000031577 and listed on NYSE Euronext, Virbac continues to leverage its expertise to enhance the well-being of animals across various sectors. Their commitment extends beyond just maintaining financial health; they strive to innovate in health solutions for animals.
Contact Information
For any inquiries or further information, stakeholders can reach out to Virbac’s financial department directly by calling 04 92 08 71 32 or via email at finances@virbac.com. Their official website also provides additional insights into their operations and commitments to animal health.
Frequently Asked Questions
What is the significance of Virbac’s share declaration?
This declaration provides essential information on the company’s capital structure and voting rights, crucial for current and potential investors.
How many total shares does Virbac have?
Virbac has a total of 8,390,660 shares, reflecting its financial strategy and market standing.
What are voting rights and why are they important?
Voting rights allow shareholders to participate in corporate governance decisions, making them vital for maintaining investor control over the company’s direction.
How can investors contact Virbac for more information?
Investors can reach Virbac’s financial department by phone at 04 92 08 71 32 or email at finances@virbac.com for any inquiries.
Where is Virbac listed?
Virbac is listed on the NYSE Euronext, under the ISIN code FR0000031577, signaling its presence in the financial markets and commitment to shareholder engagement.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.